Ko W J, Chen Y S, Lee Y C
Department of Surgery, National Taiwan University Hospital, 7 Chung-Shan S. Road, Taipei, Taiwan.
Artif Organs. 2001 Aug;25(8):607-12. doi: 10.1046/j.1525-1594.2001.025008607.x.
Cardiopulmonary bypass (CPB) is required in some lung transplantation (LTx) operations. However, it increases risks of bleeding and early graft dysfunction. We report our experiences of replacing CPB with heparin-bound extracorporeal membrane oxygenation (ECMO) in LTx operations. If extracorporeal circulation was anticipated for the LTx operations, ECMO support was set up through the femoral venoarterial route after induction of anesthesia; then, LTx was done as usual. Five thousand units of heparin was injected intravenously during the femoral vessels cannulation, but no more was used during the first 24 h of ECMO support. If necessary, as in patients undergoing single LTx for end-stage pulmonary hypertension, the ECMO support was directly extended into the postoperative period until reperfusion edema of the graft lung subsided. Twelve single LTxs and 3 bilateral sequential single LTxs were done under ECMO support. The advantages of using femoral ECMO rather than conventional CPB in LTx operations were the operative field was not disturbed by the bypass cannula, stable cardiopulmonary function and normothermia were maintained throughout the operations, there were less blood loss and transfusion requirements, and the left LTx was as easily performed as the right LTx. Red blood cell transfusion requirements during the operation and the first postoperative day were 4.4 +/- 2.8 and 2.4 +/- 2.0 U, respectively, in 10 adult patients undergoing uncomplicated single LTx with ECMO support, and 4.3 +/- 1.3 and 1.5 +/- 1.5 U in 8 adult patients undergoing single LTx without any extracorporeal circulatory support. The difference was not significant between the 2 groups (p = 0.53 and 0.32 by Mann-Whitney U test). The ECMO did not increase blood transfusion requirements. In comparison, 13 U of red blood cell transfusion was required in 2 patients receiving single LTx under CPB support. The ECMO support made the postoperative critical care easier in recipients with graft lung edema. Except for 2 cases of primary graft failure, the ECMO could be weaned off and removed at bedside within a short period (27.9 +/- 24.6 h, n = 13) with no major complications. In conclusion, the heparin-bound femoral ECMO rather than CPB should be used for LTx operations unless concomitant cardiac repair is planned.
一些肺移植(LTx)手术需要体外循环(CPB)。然而,这会增加出血风险和早期移植物功能障碍。我们报告了在LTx手术中用肝素结合体外膜肺氧合(ECMO)替代CPB的经验。如果预计LTx手术需要体外循环,在麻醉诱导后通过股静脉 - 动脉途径建立ECMO支持;然后,按常规进行LTx手术。在股血管插管期间静脉注射5000单位肝素,但在ECMO支持的最初24小时内不再使用。如有必要,如在接受终末期肺动脉高压单肺移植的患者中,ECMO支持直接延长至术后,直到移植肺的再灌注水肿消退。在ECMO支持下进行了12例单肺移植和3例双侧序贯单肺移植。在LTx手术中使用股静脉ECMO而非传统CPB的优点是手术视野不受旁路插管干扰,整个手术过程中心肺功能稳定且维持正常体温,失血和输血需求较少,左肺移植和右肺移植一样容易进行。在10例接受ECMO支持的无并发症单肺移植的成年患者中,手术期间和术后第一天的红细胞输血需求量分别为4.4±2.8单位和2.4±2.0单位,而在8例未接受任何体外循环支持的成年单肺移植患者中,分别为4.3±1.3单位和1.5±1.5单位。两组之间差异无统计学意义(Mann-Whitney U检验,p = 0.53和0.32)。ECMO并未增加输血需求。相比之下,2例接受CPB支持下单肺移植的患者需要13单位红细胞输血。ECMO支持使移植肺水肿的受者术后重症监护更容易。除2例原发性移植物功能衰竭外,ECMO可在短时间内(27.9±24.6小时,n = 13)在床边撤离并移除,无重大并发症。总之,除非计划同时进行心脏修复,否则肝素结合股静脉ECMO而非CPB应用于LTx手术。